These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11733927

  • 1. The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia.
    Buysse C, Fonteyne C, Dessy H, De Laet MH, Biarent D.
    J Pediatr Surg; 2001 Dec; 36(12):1864-5. PubMed ID: 11733927
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension.
    Pérez-Peñate G, Cabrera Navarro P, Ponce González M, Górriz Gómez E, Pulido Duque J, García Quintana A, Juliá Serdá G.
    Respiration; 2005 Dec; 72(4):419-22. PubMed ID: 16088287
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F, Casali G, Franchi G, Auriemma S, Lusini M, Barozzi L, Favaro A, Messina A, Mazzucco A.
    Int J Cardiol; 2005 Aug 18; 103(2):156-63. PubMed ID: 16080974
    [Abstract] [Full Text] [Related]

  • 6. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW, Ivy DD, Wiggins JW, Kinsella JP, Clarke WR, Abman SH.
    Am J Respir Crit Care Med; 1998 Nov 18; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.
    Ivy DD, Kinsella JP, Ziegler JW, Abman SH.
    J Thorac Cardiovasc Surg; 1998 Apr 18; 115(4):875-82. PubMed ID: 9576224
    [Abstract] [Full Text] [Related]

  • 10. Early outcome of congenital diaphragmatic hernia in a Malaysian tertiary centre.
    Rohana J, Boo NY, Thambidorai CR.
    Singapore Med J; 2008 Feb 18; 49(2):142-4. PubMed ID: 18301842
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhaled nitric oxide in the neonate.
    Soll RF.
    J Perinatol; 2009 May 18; 29 Suppl 2():S63-7. PubMed ID: 19399012
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG.
    Heart Dis; 2000 May 18; 2(5):342-7. PubMed ID: 11728280
    [Abstract] [Full Text] [Related]

  • 16. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S, Bekker JM, Ovadia B, Stuart RB, Johengen MJ, Black SM, Fineman JR.
    J Thorac Cardiovasc Surg; 2004 May 18; 127(5):1285-92. PubMed ID: 15115984
    [Abstract] [Full Text] [Related]

  • 17. Neurally adjusted ventilatory assist mode used in congenital diaphragmatic hernia.
    Durrani NU, Chedid F, Rahmani A.
    J Coll Physicians Surg Pak; 2011 Oct 18; 21(10):637-9. PubMed ID: 22015130
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The outcome in newborns with congenital diaphragmatic hernia in a Norwegian region.
    Fredly S, Aksnes G, Viddal KO, Lindemann R, Fugelseth D.
    Acta Paediatr; 2009 Jan 18; 98(1):107-11. PubMed ID: 18795908
    [Abstract] [Full Text] [Related]

  • 20. The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide.
    al-Alaiyan S, al-Omran A, Dyer D.
    Intensive Care Med; 1996 Oct 18; 22(10):1093-5. PubMed ID: 8923076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.